Skip to main content
Top
Published in: Calcified Tissue International 4/2017

01-04-2017 | Original Research

Location of Vertebral Fractures is Associated with Bone Mineral Density and History of Traumatic Injury

Authors: Jennifer Watt, Richard Crilly

Published in: Calcified Tissue International | Issue 4/2017

Login to get access

Abstract

The upper and lower thoracolumbar spine have been associated with different biomechanical outcomes. This concept, as it applies to osteoporotic fracture risk, has not been well documented. This was a case-control study of 120 patients seen in an osteoporosis clinic. Vertebral fractures were identified from lateral radiographs using Genant’s semi-quantitative assessment method. An association between bone mineral density (BMD) T-scores and vertebral fracture location was assessed. In an additional analysis, the association between a history of any traumatic injury and possible predictor variables was also explored. The median age of patients was 75 (IQR 67–80), and 84.2% of patients were female. A history of trauma was reported by 46.7% of patients. A vertebral fracture in the lower thoracolumbar spine (T11–L4) was associated with significantly higher femoral neck (p < 0.001), lumbar (p = 0.005), trochanteric (p = 0.002), intertrochanteric (p < 0.001), and total hip (p = 0.0006) BMD T-scores. The odds of having a femoral neck (OR 0.24, 95% CI 0.07–0.75, p = 0.01) or total hip (OR 0.19, 95% CI 0.06–0.65, p = 0.008) T-score less than −2.5 was also lower among patients with vertebral fractures in the lower thoracolumbar spine. A fracture in the upper thoracolumbar spine (T4–T10) decreased the odds of having a history of traumatic injury (OR 0.32, 95% CI 0.14–0.76, p = 0.01), while a non-vertebral fracture increased the odds of such an injury (OR 2.41, 95% CI 1.10–5.32, p = 0.03). Vertebral fractures in the lower thoracolumbar spine are associated with higher BMD T-scores. This should be studied further to understand possible correlations with patients’ future fracture risk.
Literature
1.
go back to reference Looker A, Orwoll E, Johnston C, Lindsay R, Wahner H, Dunn W, Calvo M, Harris T, Heyse S (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12(11):1761–1768CrossRefPubMed Looker A, Orwoll E, Johnston C, Lindsay R, Wahner H, Dunn W, Calvo M, Harris T, Heyse S (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12(11):1761–1768CrossRefPubMed
2.
go back to reference Kanis J, Melton L, Christiansen C, Johnston C, Khaltaev N (1994) Perspective: the diagnosis of osteoporosis. J Bone Miner Res 9(8):1137–1141CrossRefPubMed Kanis J, Melton L, Christiansen C, Johnston C, Khaltaev N (1994) Perspective: the diagnosis of osteoporosis. J Bone Miner Res 9(8):1137–1141CrossRefPubMed
3.
go back to reference Kanis J, The WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Osteoporos Int 4:368–381CrossRefPubMed Kanis J, The WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Osteoporos Int 4:368–381CrossRefPubMed
4.
go back to reference Ioannidis B, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD (2009) Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ 181(5):265–271CrossRefPubMedPubMedCentral Ioannidis B, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD (2009) Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ 181(5):265–271CrossRefPubMedPubMedCentral
5.
go back to reference Papaioannou A, Adachi JD, Parkinson W, Stephenson G, Bédard M (2001) Lengthy hospitalization associated with vertebral fractures despite control for comorbid conditions. Osteoporos Int 12(10):870–874CrossRefPubMed Papaioannou A, Adachi JD, Parkinson W, Stephenson G, Bédard M (2001) Lengthy hospitalization associated with vertebral fractures despite control for comorbid conditions. Osteoporos Int 12(10):870–874CrossRefPubMed
6.
go back to reference Browner SR, Seeley WS, Vogt DG, Cummings TM (1991) Non-trauma mortality in elderly women with low bone mineral density. Lancet 338:355–358CrossRefPubMed Browner SR, Seeley WS, Vogt DG, Cummings TM (1991) Non-trauma mortality in elderly women with low bone mineral density. Lancet 338:355–358CrossRefPubMed
7.
go back to reference Johnell O, Kanis JA (2004) An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 15(11):897–902CrossRefPubMed Johnell O, Kanis JA (2004) An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 15(11):897–902CrossRefPubMed
8.
go back to reference Ooms ME, Lips P, Van Lingen A, Valkenburg HA (1993) Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women. J Bone Miner Res 8(6):669–675CrossRefPubMed Ooms ME, Lips P, Van Lingen A, Valkenburg HA (1993) Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women. J Bone Miner Res 8(6):669–675CrossRefPubMed
9.
go back to reference Arden NK, Baker J, Hogg C, Baan K, Spector TD (1996) The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 11(4):530–534CrossRefPubMed Arden NK, Baker J, Hogg C, Baan K, Spector TD (1996) The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 11(4):530–534CrossRefPubMed
10.
go back to reference Law MR, Hackshaw AK (1997) A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 315:841–846CrossRefPubMedPubMedCentral Law MR, Hackshaw AK (1997) A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 315:841–846CrossRefPubMedPubMedCentral
11.
go back to reference Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, Mcclung M, Hosking D, Yates AJ, Christiansen C (1999) Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J Bone Miner Res 14(9):1622–1627CrossRefPubMed Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, Mcclung M, Hosking D, Yates AJ, Christiansen C (1999) Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J Bone Miner Res 14(9):1622–1627CrossRefPubMed
12.
go back to reference Kroger H, Tuppurainen M, Honkanen R, Alhava E, Saarikoski S (1994) Bone mineral density and risk factors for osteoporosis: a population-based study of 1600 perimenopausal women. Calcif Tissue Int 55(1):1–7CrossRefPubMed Kroger H, Tuppurainen M, Honkanen R, Alhava E, Saarikoski S (1994) Bone mineral density and risk factors for osteoporosis: a population-based study of 1600 perimenopausal women. Calcif Tissue Int 55(1):1–7CrossRefPubMed
13.
go back to reference Lips P (1997) Epidemiology and predictors of fractures associated with osteoporosis. Am J Med 103(2A):3S–8SCrossRefPubMed Lips P (1997) Epidemiology and predictors of fractures associated with osteoporosis. Am J Med 103(2A):3S–8SCrossRefPubMed
14.
go back to reference Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280(24):2077–2082CrossRefPubMed Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280(24):2077–2082CrossRefPubMed
15.
go back to reference McClung MR, Geusens P, Miller PD, Zippel H et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344(5):333–340CrossRefPubMed McClung MR, Geusens P, Miller PD, Zippel H et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344(5):333–340CrossRefPubMed
16.
go back to reference Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res 11(7):984–996CrossRefPubMed Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res 11(7):984–996CrossRefPubMed
17.
go back to reference Van der Klift M, De Laet CEDH, McCloskey EV, Hofman A, Pols HAP (2002) The incidence of vertebral fractures in men and women: the Rotterdam study. J Bone Miner Res 17(6):1051–1056CrossRefPubMed Van der Klift M, De Laet CEDH, McCloskey EV, Hofman A, Pols HAP (2002) The incidence of vertebral fractures in men and women: the Rotterdam study. J Bone Miner Res 17(6):1051–1056CrossRefPubMed
18.
go back to reference Watt J, Cox L, Crilly RG (2015) Distribution of vertebral fractures varies among patients according to hip fracture type. Osteoporos Int 26:885–890CrossRefPubMed Watt J, Cox L, Crilly RG (2015) Distribution of vertebral fractures varies among patients according to hip fracture type. Osteoporos Int 26:885–890CrossRefPubMed
19.
go back to reference Nevitt MC, Ross PD, Palermo L, Musliner T, Genant HK, Thompson DE (1999) Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures. Bone 25(5):613–619CrossRefPubMed Nevitt MC, Ross PD, Palermo L, Musliner T, Genant HK, Thompson DE (1999) Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures. Bone 25(5):613–619CrossRefPubMed
20.
go back to reference Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164(10):1108–1112CrossRefPubMed Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, Berger ML (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164(10):1108–1112CrossRefPubMed
21.
go back to reference Sanders KM, Pasco JA, Ugoni AM, Nicholson GC, Seeman E, Martin TJ, Skoric B, Panahi S, Kotowicz MA (1998) The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res 13(8):1337–1342CrossRefPubMed Sanders KM, Pasco JA, Ugoni AM, Nicholson GC, Seeman E, Martin TJ, Skoric B, Panahi S, Kotowicz MA (1998) The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res 13(8):1337–1342CrossRefPubMed
22.
go back to reference Craig SJ, Youssef PP, Vaile JH, Sullivan L, Bleasel JF (2011) Intravenous zoledronic acid and oral alendronate in patients with a low trauma fracture: experience from an osteoporosis clinic. Intern Med J 41(2):186–190CrossRefPubMed Craig SJ, Youssef PP, Vaile JH, Sullivan L, Bleasel JF (2011) Intravenous zoledronic acid and oral alendronate in patients with a low trauma fracture: experience from an osteoporosis clinic. Intern Med J 41(2):186–190CrossRefPubMed
23.
24.
go back to reference Yoganandan N, Arun MWJ, Stemper BD, Pintar FA, Maiman DJ (2013) Biomechanics of human thoracolumbar spinal column trauma from vertical impact loading. Ann Adv Automot Med 57:155–166PubMedPubMedCentral Yoganandan N, Arun MWJ, Stemper BD, Pintar FA, Maiman DJ (2013) Biomechanics of human thoracolumbar spinal column trauma from vertical impact loading. Ann Adv Automot Med 57:155–166PubMedPubMedCentral
25.
go back to reference Ivancic PC (2014) Biomechanics of thoracolumbar burst and chance-type fractures during fall from height. Global. Spine J 4:161–168 Ivancic PC (2014) Biomechanics of thoracolumbar burst and chance-type fractures during fall from height. Global. Spine J 4:161–168
26.
go back to reference Campbell-Kyureghyan NH, Yalla SV, Voor M, Burnett D (2011) Effect of orientation on measured failure strengths of thoracic and lumbar spine segments. J Mech Behav Biomed Mater 4(4):549–557CrossRefPubMed Campbell-Kyureghyan NH, Yalla SV, Voor M, Burnett D (2011) Effect of orientation on measured failure strengths of thoracic and lumbar spine segments. J Mech Behav Biomed Mater 4(4):549–557CrossRefPubMed
Metadata
Title
Location of Vertebral Fractures is Associated with Bone Mineral Density and History of Traumatic Injury
Authors
Jennifer Watt
Richard Crilly
Publication date
01-04-2017
Publisher
Springer US
Published in
Calcified Tissue International / Issue 4/2017
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-017-0244-9

Other articles of this Issue 4/2017

Calcified Tissue International 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.